Conference

SITC Annual Meeting

Book a meeting with us

November 1-4

San Diego, CA

Visit our booth #530

Dissecting cancer: from sample to data

Cancer immunotherapy has seen increasing clinical success in the past decade. To further innovate and continue to improve therapeutical approaches, researchers are seeking for a better understanding of the underlying mechanisms controlling anti-cancer immune response as well as cancer-intrinsic resistance. Meet Lunaphore at SITC 2023 to learn more on how spatial proteomics provides unprecedented and detailed views on cell phenotypes and the cell-to-cell interactions that support a better understanding of such interventions and tissue biology.
Discover our spatial biology solutions and learn how to get from samples to data.

BOOTH #530: PRODUCT DEMO & RAW DATASET

Make sure to stop by the Lunaphore booth to receive a 2-minute walkthrough of the COMET platform and freely browse raw multiplex images on several tissue types. Book a meeting with our team to learn how top-notch laboratories, biopharma and CROs are leveraging COMET™: the only fully automated, high-throughput, hyperplex platform that works with off-the-shelf, label-free primary antibodies.

📅 November 3 – 4
📍 Booth #530

BOOK A MEETING WITH LUNAPHORE →
(Clicking on the link you will be able to select your preferred meeting time)

 

Sponsored Symposium – Room 15AB

Book your agenda to know more about how the collaborators at the Earle A. Chiles Research Institute (EACRI) at Providence Health exploited the COMET™ platform on a project to develop a hyperplex immunofluorescence panel for the comprehensive characterization of the tumor microenvironment in response to combined immunotherapy and stereotactic ablative radiation therapy (iSABR) neoadjuvant treatment of head and neck squamous cell carcinoma (HNSCC). Check the full talk abstract below.

Using hyperplex immunofluorescence to characterize the immune response to iSABR in head and neck cancer
Speakers:

Brian Piening, PhD – Providence Cancer Institute – Earle A. Chiles Research Institute
Rom Leidner, MD – Providence Cancer Institute – Earle A. Chiles Research Institute

📅 November 3 | 1:15 PM
📍 Room 15AB

 

 

POSTER PRESENTATIONS – Scientific program

The novel data brought at SITC 2023 will outline COMET™’s industry-leading capabilities and highlight its wide range of research applications and broad clinical potential. 

Poster #65 – data generated by Providence Cancer Institute
Development and optimization of a broad hyperplex immunofluorescence assay for tumor immune microenvironment characterization

Poster #71 – in collaboration with ACD
Integration of RNA in situ hybridization and sequential immunofluorescence for same-slide fully automated multi-omics analysis of the tumor microenvironment

Poster #107 – in collaboration with the Swiss Institute for Experimental Cancer Research
Adding space to TiME by sequential immunofluorescence: a new dimension for the spatial Biomarkers painting in a clinical cohort of lymphoma case

Poster #1475 – data generated by Fortis Life Science
Profiling cytokeratins in the tumor microenvironment using multiplex immunofluorescence

Poster #102 – data generated by Massachusetts General Hospital and Harvard Medical School
Immune landscape of adenoid cystic carcinoma using multiplex immunofluorescence and digital pathology

Poster #222-D – data generated by A* Singapore
Automated hyperplex staining and imaging system on various cancer tissues using off the shelf antibodies

Lunaphore solutions will be featured in the following poster presentations.:

Poster #65 – data generated by Providence Cancer Institute
Development and optimization of a broad hyperplex immunofluorescence assay for tumor immune microenvironment characterization

📋 Primary Category – Biomarkers, Immune Monitoring and Novel Technologies
📅 November 3 || 12:00 – 1:30 PM | 5:10 – 6:40 PM


Poster #71 – in collaboration with ACD
Integration of RNA in situ hybridization and sequential immunofluorescence for same-slide fully automated multi-omics analysis of the tumor microenvironment

📋 Primary Category – Biomarkers, Immune Monitoring and Novel Technologies
📅 November 3 || 12:00 – 1:30 PM | 5:10 – 6:40 PM


Poster #107 – in collaboration with the Swiss Institute for Experimental Cancer Research
Adding space to TiME by sequential immunofluorescence: a new dimension for the spatial Biomarkers painting in a clinical cohort of lymphoma case

📋 Primary Category – Biomarkers, Immune Monitoring and Novel Technologies
📅 November 3 || 12:00 – 1:30 PM | 5:10 – 6:40 PM


Poster #1475 – data generated by Fortis Life Science
Profiling cytokeratins in the tumor microenvironment using multiplex immunofluorescence

📋 Primary Category – Tumor and Stromal Cell Biology
📅 November 3 || 12:00 – 1:30 PM | 5:10 – 6:40 PM


Poster #102 – data generated by Massachusetts General Hospital and Harvard Medical School
Immune landscape of adenoid cystic carcinoma using multiplex immunofluorescence and digital pathology

📋 Primary Category – Biomarkers, Immune Monitoring and Novel Technologies
📅 November 4 || 11:55 – 1:25 PM | 7:00 – 8:30 PM


Poster #222-D – data generated by A* Singapore
Automated hyperplex staining and imaging system on various cancer tissues using off the shelf antibodies

📋 Primary Category – Biomarkers, Immune Monitoring and Novel Technologies
📅 November 4 || 11:55 – 1:25 PM | 7:00 – 8:30 PM

Visit booth #530 to check our latest product releases.

Lunaphore’s multiplex immunofluorescence (mIF) solution portfolio now includes the latest version of the hyperplex, high-throughput, fully automated COMET™ instrument, providing unmatched scalability and reproducibility without the need to conjugate primary antibodies. The new SPYRE™ Antibody Panel kits, Secondary Antibodies, and an online Panel Builder have been added to the existing offering to help kick-start assay development and enable users with verified biomarkers on COMET™.

The product suite is further complemented by HORIZON™, an image analysis software designed and tailored for COMET™ hyperplex images. It seamlessly extends the COMET™ workflow, smoothly handling large data sets. This user-friendly analysis tool supports cell-based analysis and provides researchers with a toolset for early and high-level assessment of data in a hyperplex immunofluorescent image. With Lunaphore’s universal portfolio of precision automation solutions, customers can leverage their existing antibody libraries and decades of know-how on Lunaphore’s platform to scale assays into endless multiplexing possibilities.

For info, meeting requests, or support please contac[email protected].

November 3

Sponsored Symposium

November 3

12:15 - 1:15 PM

Room 15AB

Collaborators from the Earle A. Chiles Research Institute (EACRI) at Providence Health and Lunaphore report on a project to develop a hyperplex immunofluorescence panel on the COMET platform for the comprehensive characterization of the tumor microenvironment in response to combined immunotherapy and stereotactic ablative radiation therapy (iSABR) neoadjuvant treatment of head and neck squamous cell carcinoma (HNSCC). The team will discuss strategies for rapid hyperplex seqIF panel development and optimization as well as methodologies for high-throughput data analytics. The team will show results of tumor-immune microenvironment remodeling in a spatiotemporal context, for neoadjuvant iSABR in HNSCC.

Speakers

Marco Cassano, Ph.D.

Marco Cassano, Ph.D.

Head of Scientific Affairs

Lunaphore

Brian Piening, PhD

Brian Piening, PhD

Technical director, Molecular Genomics Laboratory

Providence Cancer Institute – Earle A. Chiles Research Institute, Portland, Oregon, USA

Dr. Piening is trained in genetics, genomics and bioinformatics. Along with leading the Cancer Immuno-Genomics Lab at the Earle A. Chiles Research Institute, a Providence Center of Excellence for immuno-oncology and cellular therapy, he also serves as technical director of Clinical Genomics at the Providence Molecular Genomics Lab. There, he uses comprehensive genomic profiling to develop personalized treatment plans for people with advanced cancer. The laboratory is one of only a handful in the world that performs whole genome sequencing in a clinical context and is the dedicated clinical sequencing facility for Providence. Dr. Piening oversees the Molecular Pathology Core facility at the Earle A. Chiles Research Institute. He also serves as an assistant professor for bioinformatics and medical education at the University of Washington and assistant professor of biology at Portland State University.
Rom Leidner, MD

Rom Leidner, MD

Providence Cancer Institute – Earle A. Chiles Research Institute, Portland, Oregon, USA